| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.11. | Coya Therapeutics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| COYA THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 10.11. | Coya Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.10. | Coya Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 06.10. | Coya Therapeutics: H.C. Wainwright bestätigt Kaufempfehlung nach Abschluss der Patientenrekrutierung für ALS-Studie | 1 | Investing.com Deutsch | ||
| 06.10. | Coya Therapeutics stock reiterated at Buy by H.C. Wainwright on trial enrollment | 1 | Investing.com | ||
| 05.10. | Coya Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.09. | Coya Therapeutics stock maintained at Buy by H.C. Wainwright | 2 | Investing.com | ||
| 25.09. | H.C. Wainwright bestätigt "Buy"-Rating für Coya Therapeutics Aktie | 1 | Investing.com Deutsch | ||
| 15.09. | Coya Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.08. | H.C. Wainwright reiterates Coya Therapeutics stock rating at buy | 1 | Investing.com | ||
| 11.08. | Coya Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $0.24M beats by $0.14M | 1 | Seeking Alpha | ||
| 11.08. | Coya Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.08. | Coya Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 25.06. | Coya Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | Roth/MKM stuft Coya Therapeutics mit Kaufempfehlung und hohem Kursziel ein | 3 | Investing.com Deutsch | ||
| 05.06. | Roth/MKM initiates Coya Therapeutics stock with buy rating | 1 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 78,30 | +0,84 % | BioNTech-Aktie: Totes Kapital? | Die Aktie von BioNTech bleibt trotz des rückläufigen Impfstoffgeschäfts ein spannender Titel am Aktienmarkt. Anleger richten ihren Blick zunehmend auf die milliardenschwere Forschungspipeline im Bereich... ► Artikel lesen | |
| EVOTEC | 2,966 | -5,06 % | Evotec-Aktie: Gewinn- und Umsatzrekord? | Die Aktie des Hamburger Wirkstoffforschers Evotec bleibt ein spannender, aber risikoreicher Titel am deutschen Aktienmarkt. Nach schwierigen Monaten sorgen erste operative Fortschritte, neue Partnerschaften... ► Artikel lesen | |
| BB BIOTECH | 58,00 | -1,36 % | Christian Koch, Leiter BB Biotech Team bei Bellevue Asset Management, im Interview | von Robert Jakob Moneycab.com: Herr Koch, acht bestehende Beteiligungen verkauft, zwölf neue Positionen aufgebaut, das sieht nach einer grösseren Rochade aus? Die Veränderungen spiegeln unser aktives... ► Artikel lesen | |
| MEDIGENE | 0,003 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.06.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 30.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.06.2026ISIN NameBE0003593044 COFINIMMOCA8765111064 TASEKO... ► Artikel lesen | |
| QIAGEN | 45,310 | +0,13 % | QIAGEN N.V.: QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director | QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that shareholders overwhelmingly approved the appointment of Jonathan M. Pratt as a Managing Director and member of the QIAGEN... ► Artikel lesen | |
| BIOGEN | 230,35 | +0,13 % | TRIMTECH Therapeutics Enters Strategic Research Collaboration With Biogen to Advance Small Molecule Degraders for Neurodegenerative Disease | Collaboration with Biogen will leverage TRIMTECH's proprietary TRIM21-based targeted protein degradation technology to develop novel protein degrading therapeutics for neurodegenerative diseases.... ► Artikel lesen | |
| HEIDELBERG PHARMA | 2,140 | +3,38 % | Formycon, Heidelberg Pharma und Medios: Biotech-Nebenwerte zwischen Analystenrückenwind und stillen Kursen | ||
| ILLUMINA | 182,46 | -2,85 % | Illumina Inc. Bottom Line Rises In Q3 | SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) announced a profit for its third quarter that Increases, from last yearThe company's bottom line came in at $220 million, or $1.43 per share. This... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 38,200 | -0,27 % | CRISPR Therapeutics Highlights Substantial Lipid Reductions with Investigational Gene Editing Therapy | ||
| INTELLIA THERAPEUTICS | 9,280 | +5,33 % | Intellia stock price target maintained at $30 by Citizens on HAE data | ||
| NUREXONE BIOLOGIC | 0,281 | -8,77 % | 14 Tage oder 60 Monate Lagerung: Warum Gilead, Mesoblast und NurExone regenerative Therapien unterschiedlich verfügbar machen | ||
| GUBRA | 40,320 | -0,69 % | Gubra A/S: Change of executive leadership at Gubra | The Board of Directors of Gubra today announces that Markus Rohrwild is stepping down as CEO of the company, effective today, November 10, 2026. The Board has appointed Kristian Borbos, Chief Financial... ► Artikel lesen | |
| ARROWHEAD PHARMACEUTICALS | 41,700 | -3,76 % | Arrowhead Pharmaceuticals, Inc.: Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conferences | Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming investor events:2026 Jefferies Global Healthcare Conference in London November... ► Artikel lesen | |
| LAKEFRONT BIOTHERAPEUTICS | 31,060 | -2,77 % | Lakefront Biotherapeutics: Lakefront Initiates New €50 Million Share Repurchase Program Following Completion of Initial Share Repurchase Program | Mechelen, Belgium; November 16, 2026; 7.30 AM CET regulated information - Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced the initiation of a new share repurchase program of up... ► Artikel lesen | |
| SOL GLOBAL INVESTMENTS | 0,026 | -100,00 % | SOL Global Investments Corp.: SOL Global Announces Resignation of Deena Siblock and Conclusion of Consulting Arrangement | Toronto, Ontario--(Newsfile Corp. - October 26, 2026) - SOL GLOBAL INVESTMENTS CORP. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB0) ("SOL Global" or the "Company") announces that Deena Siblock has resigned... ► Artikel lesen |